Trials / Suspended
SuspendedNCT04211129
Effect of Acupuncture on Patients With Crohn's Disease in Remission
Effect of Acupuncture on Crohn's Disease Via the Regulation of Trp-kyn Metabolism in Brain-gut Axis
- Status
- Suspended
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Shanghai Institute of Acupuncture, Moxibustion and Meridian · Academic / Other
- Sex
- All
- Age
- 16 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
To observe the therapeutic effect of acupuncture on Crohn's disease in remission and its influence of brain functional activity
Detailed description
1. Effect of acupuncture on symptoms (functional gastrointestinal symptoms, Fatigue, insomnia, depression, anxiety and perceived stress)of CD 2. Effect of acupuncture on brain functional activity of CD
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | acupuncture | Patients receiving acupuncture and mild moxibustion, whom were treated 3 times per week for 12 weeks and followed up for 36 weeks. CV12 and Bilateral ST37, SP6, SP4, LR3, KI3, LI4 and LI11 were selected for acupuncture and bilateral ST25 and ST36 were selected for moxibustion. Hwato acupuncture device was used to blind the subjects, and had the deqi sensation. The surface temperature of acupoints was maintained at 43℃± 1℃ for moxibustion. |
| OTHER | Sham acupuncture | Patients receiving sham acupuncture and sham mild moxibustion, whom were treated 3 times per week for 12 weeks and followed up for 36 weeks. CV12 and Bilateral ST37, SP6, SP4, LR3, KI3, LI4 and LI11 were selected for acupuncture and bilateral ST25 and ST36 were selected for moxibustion. Same Hwato acupuncture device was used to blind the subjects, but do not puncturing into the skin and do not have the deqi sensation. The surface temperature of acupoints was maintained at 37℃± 1℃ for moxibustion. |
Timeline
- Start date
- 2019-07-01
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2019-12-26
- Last updated
- 2025-05-16
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04211129. Inclusion in this directory is not an endorsement.